Liana K Billings, MD, MMSc

Diabetes doc, Vice Chair of Research in DOM @NorthShoreWeb #precisionmedicine #clinicaltrials #EndoTwitter

[Liana K Billings, MD, MMSc @lbillingsmd]

Wonderful talk on Treatment Simplification for our diabetes patients by Drs. Leigh Perrault and Francesco Giorgino discussing FRCs of basal insulin & GLP-1RA. It’s time to use diabetes therapies that are effective and reduce treatment burden. Less can mean more! #EASD2022

[Liana K Billings, MD, MMSc @lbillingsmd]

@AliceYYCheng Right back at you, Alice! Great to finally meet you in person!

[Liana K Billings, MD, MMSc @lbillingsmd]

@annagloyn Dr. Anna - you are an inspiration for all in science, a role model, making the seemingly impossible — possible!, and a wonderfully kind and warm person. Congratulations on a well-deserved award!

[Liana K Billings, MD, MMSc @lbillingsmd]

Eye opening talk from Dr. Sara Cromer @sjcromermd on racial and ethnic disparities in GLP-1RA and SGLT2i use. Let's critically examine our own healthsystems & find ways we can make sure all people have access to therapies that improves blood glucose and reduce risk of MACE.

[The diaTribe Foundation @diaTribeNews]

From #ADA2022 - "We are all looking for the time in range in studies now. We need to know what it really means for our patients!" - Dr. Grazia Aleppo, MD

[The diaTribe Foundation @diaTribeNews]

From #ADA2022 - “15% weight loss is the new 7% A1c,” said Ildiko Lingvay, MD, MPH, MSCS, in arguing that Obesity Should Be the Primary Target of Treatment in Type 2 Diabetes

[Liana K Billings, MD, MMSc @lbillingsmd]

https://t.co/OaSiotWbT2

[Liana K Billings, MD, MMSc @lbillingsmd]

Dr. Ildi Lingvay just provided a compelling, thoughtful, and beautifully presented talk on weight loss being our primary target for treatment of diabetes. Thanks for teaching me a new word #adiposopathy! #ADA2022

[NEJM @NEJM]

SURMOUNT-1: In an RCT, adults with obesity treated with weekly tirzepatide had major weight loss over 72 weeks. #ADA2022 https://t.co/X2RrvYxzsV

[Liana K Billings, MD, MMSc @lbillingsmd]

Beautifully presented @AniaJastreboff - exciting results and incredibly impactful for our patients with obesity.

[Filip K. Knop @Filip_Knop]

SURMOUNT-1 data presented @#ADA2022 by @AniaJastreboff 👏🏼🤩🦾
A new era in anti-obesity meditations!
@LillyPad

[Filip K. Knop @Filip_Knop]

SURMOUNT-1 data presented @#ADA2022 by @AniaJastreboff 👏🏼🤩🦾
A new era in anti-obesity meditations!
@LillyPad

[Liana K Billings, MD, MMSc @lbillingsmd]

Just finished teaching about the use of GLP-1RA and stroke risk reduction in patients with T2D at the #ADA2022

[Liana K Billings, MD, MMSc @lbillingsmd]

Great job, Dr. Aroda, discussing the data on prediabetes and the progression to diabetes & how this has impacted our guidelines in A1c monitoring. Thank you to you and the team for the ADA guidelines & guiding our clinical care so we can provide the best care! #ADA2022 @ArodaMd

[Liana K Billings, MD, MMSc @lbillingsmd]

This article inspires hope! So grateful for the researchers and volunteers who make these discoveries possible! #t1d #diabuzz https://t.co/2r6qo6MzHJ

[Diabetes Daily @diabetesdaily]

"I was diagnosed in February, 1970 with #Type1Diabetes at the age of 12. I am so grateful for the many #diabetic resources & medical devices developed over my lifetime by medical researchers, scientists & physicians. My life is a healthy, joyful, & successful life." - Karen #NDAM

[Liana K Billings, MD, MMSc @lbillingsmd]

Thank you ADA! Our patients and providers need insulin to be affordable to provide the best care and try to remove disparities in care. #diabuzz

[American Diabetes Association - DiabetesPro @ADA_DiabetesPro]

We have been pressing hard for Congress to make #insulin more affordable. We are on the verge of securing a NATIONAL co-pay cap for Medicare and many private plan participants.

[Liana K Billings, MD, MMSc @lbillingsmd]

#diabuzz

[American Diabetes Association @AmDiabetesAssn]

#ADM2021 is here! Introducing this year's theme: #TheBigStepUp! Get ready to learn, move, and thrive together! Who's ready?!

[Diabetologia @DiabetologiaJnl]

Urinary NMR #metabolomics robustly quantifies broad panel of metabolites in thousands at low cost providing insights on new onset & progression of kidney disease in #T1D @FinnDianeStudy #diabetes #kidney #urine @FolkhalsanRC @NgaleHealth #helsinkihealth https://t.co/d88PIs138K 🔓

[Liana K Billings, MD, MMSc @lbillingsmd]

Always admire the resilience of people with T1D. Exactly - ‘perfection does not exist’ - stay positive! Thanks @T1DExchange for asking these questions.

[T1D Exchange @T1DExchange]

How would you describe the daily burden of T1D?🤔
The answers to this Question of the Day showed the resilience of people with T1D, and the positivity of our community.
Check out our breakdown of October’s most popular Questions of the Day: https://t.co/Io8jbCo5hl
#t1d